Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Now here's a conspiracy theory for you!

All hypothetical of course but, for some reason, I see a reverse merger of TPL into PTSC happening, instead of a TPL buyout. Not that I think it will occur, but RG does note his desire to make use of PTSC's public listing. There are private enterprise owners who would no doubt relish the idea of substantial stock price appreciation once the floodgates are opened.

Best

Share
New Message
Please login to post a reply